Related Experiment Video
Updated: Apr 25, 2026

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.0K
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis
Kristie Tanavura Bariboloka1, Santiago Serrano-Saenz1, Deniz Pinar Savcigil1
1University of Cologne, Cologne, Germany.
Blood
|April 23, 2026
Summary
Targeting cFLIP, an extrinsic apoptosis inhibitor, is crucial for treating diffuse large B cell lymphoma (DLBCL). Deleting cFLIP effectively kills DLBCL cells by enabling extrinsic apoptosis, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Diffuse large B cell lymphoma (DLBCL) is a heterogeneous cancer with challenging relapsed/refractory disease.
- Apoptosis evasion is a hallmark of DLBCL, but the role of extrinsic apoptosis remains unclear.
- cFLIP is a key inhibitor of extrinsic apoptosis.
Purpose of the Study:
- To investigate the role of cFLIP in DLBCL development and treatment.
- To determine if targeting cFLIP can overcome apoptosis resistance in DLBCL.
- To explore cFLIP's function beyond apoptosis regulation.
Main Methods:
- Genetic deletion of cFLIP in a murine DLBCL model.
- Analysis of human DLBCL cell lines (ABC and GCB subtypes).
- Assessment of apoptosis induction and cytokine expression.
Main Results:
- B cell-specific deletion of cFLIP prevented lymphomagenesis in mice.
- Absence of cFLIP sensitized ABC DLBCL cells to TRAIL/LPS-induced apoptosis.
- cFLIP suppressed pro-inflammatory cytokines transcriptionally in ABC DLBCL.
Conclusions:
- Extrinsic apoptosis control is essential for DLBCL pathogenesis.
- Targeting cFLIP can promote DLBCL cell death via extrinsic apoptosis.
- cFLIP inhibitors are a promising therapeutic strategy for ABC DLBCL.
Related Concept Videos
B Cell Activation and Differentiation
14.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.3K
T Cell Activation and Clonal Selection
13.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.6K
The Intrinsic Apoptotic Pathway
6.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Cells of the Adaptive Immune Response
6.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.8K
The Extrinsic Apoptotic Pathway
6.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K

